Browse Articles

Filter By:

  • Because of the increased production of acids, the altered metabolism of tumour cells renders them especially reliant on pH-regulatory systems that ensure that the intracellular pH does not decrease too much. This Review discusses the interplay among metabolism, hypoxia and pH regulation and whether pH-regulatory systems can be targeted for anticancer therapy.

    • Scott K. Parks
    • Johanna Chiche
    • Jacques Pouysségur
    Review Article
  • The zebrafish has emerged as an important model system with which to investigate cancer, particularly for validating genomics data and for undertaking screens for oncogenes and drivers of tumour progression and metastasis. This Review outlines what we have learned and could still learn from cancer research using the zebrafish.

    • Richard White
    • Kristin Rose
    • Leonard Zon
    Review Article
  • Many therapeutic agents target the ERBB family of receptor tyrosine kinases in various cancers. This Opinion article describes our latest understanding of the value of combining inhibitors directed towards an individual ERBB family member, including the molecular mechanisms of synergy and progress in clinical trials.

    • Niall Tebbutt
    • Mikkel W. Pedersen
    • Terrance G. Johns
    Opinion
  • This paper shows that misorientation of the spindle poles in dividing epithelial cells can lead to aberrant cell growth in the absence of apoptosis.

    • Nicola McCarthy
    Research Highlight
  • The efficacy of surgery is dependent on removing the entire tumour and also on not damaging important structures, such as nerves. Strategies, such as fluorescent labelling, are being developed to visually identify tumour cells and crucial structures in order to improve the safe resection of tumours. These methods have the potential to improve the survival of cancer patients, as discussed here.

    • Quyen T. Nguyen
    • Roger Y. Tsien
    Opinion
  • A study reported inSciencehas found that sympathetic and parasympathetic nerves are involved in prostate cancer growth and dissemination in mouse models, and has begun to elucidate the molecular pathways by which nerves affect tumours, suggesting possible therapeutic approaches.

    • Sarah Seton-Rogers
    Research Highlight
  • The data in this paper indicate that the combined treatment of pancreatic ductal adenocarcinoma in mice with gemcitabine and an antibody that targets connective tissue growth factor has greater efficacy than either treatment alone owing to a reduction in the expression levels of XIAP.

    • Nicola McCarthy
    Research Highlight
  • Endothelin 1 (ET1) is a secreted protein that can function through autocrine and paracrine signalling to modulate various properties of cancer cells and their microenvironment. This Review describes our latest understanding of the biological roles of ET1 in cancer and the results of clinical trials with drugs that target the ET1 signalling pathway.

    • Laura Rosanò
    • Francesca Spinella
    • Anna Bagnato
    Review Article
  • A new study adds weight to the evidence that air pollution is a risk factor for lung cancer.

    • Nicola McCarthy
    In the News
  • Adoptive T cell therapy using engineered T cells to improve antitumour responses is showing promise for the treatment of haematological malignancies in particular. This Review discusses the strategies to engineer T cells and the progress that has been made with using gene-modified T cells to treat cancer patients.

    • Michael H. Kershaw
    • Jennifer A. Westwood
    • Phillip K. Darcy
    Review Article
  • Offermanns and colleagues found that tumour cell-activated platelets induce endothelial opening — which promotes extravasation — through adenine nucleotide-mediated activation of P2Y2 on endothelial cells.

    • Gemma K. Alderton
    Research Highlight
  • A paper inCell reports that breast cancer cells can transition between non-cancer stem cell (CSC)-like and CSC-like states; this is dependent on ZEB1, which can be readily activated by microenvironmental signals in non-CSCs that maintain the chromatin at the ZEB1promoter in a bivalent state.

    • Sarah Seton-Rogers
    Research Highlight
  • Two recent papers indicate that increasing the turnover of MYC proteins in tumours might promote the loss of an immature, self-renewing cell population and might, therefore, have a therapeutic impact.

    • Nicola McCarthy
    Research Highlight